Thin Basement Membrane Disease

• CLINICAL_TRIALS trial_result · 2026-04-15
  Clinical Trial Update: Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT) [Phase 4]

  Phase 4 trial evaluating whether dapagliflozin, spironolactone, or their combination lowers albuminuria in adults with Alport syndrome and r…